Rates of latent tuberculosis infection in patients treated with TNF inhibitors for psoriasis: a retrospective chart review

Abstract

LTBI appears to be prevalent among psoriasis patients. Screening for LTBI in patients on biologics may reduce risk of active tuberculosis; however, current methods may not be fully effective. Clinicians may need to use other tools including risk factor assessment to fully evaluate risk.